Product Code: ETC6183948 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The lichen planus market in Australia includes treatments for both skin and mucosal variants of the disease. The demand for corticosteroids, immunosuppressants, and non-steroidal options is steady, with oral and dermatological forms being the most prescribed. Research into autoimmune-related skin disorders and newer biologic therapies is slowly reshaping treatment paradigms.
Australias lichen planus market is seeing an increasing number of patients seeking treatment due to improved diagnostic capabilities in dermatology. The use of biologics and topical corticosteroids continues to dominate the treatment landscape. Additionally, there is a trend toward personalized care plans, as practitioners consider autoimmune comorbidities and triggers such as stress and medications.
The Lichen Planus market in Australia faces several challenges, with the primary issue being the lack of a definitive cure. Lichen Planus is an inflammatory condition that affects the skin, nails, and mucous membranes, and its cause is often unclear. While treatments such as corticosteroids and immunosuppressive drugs are available, they are not always effective for every patient, and relapses are common. Furthermore, there is limited awareness about this condition among both patients and healthcare providers, leading to misdiagnosis or delayed treatment. The complexity of the condition, coupled with a relatively small patient base, results in a slow pace of research and development of novel therapies.
The growing prevalence of autoimmune skin disorders creates ample investment space in the lichen planus treatment sector. Biopharmaceutical companies working on novel corticosteroid alternatives and immune-modulating therapies stand out as promising investment opportunities. Moreover, there is rising demand for dermatology-focused telemedicine platforms and pharmacy chains stocking specialized prescription skincare products, both of which offer attractive returns.
In Australia, the government addresses the treatment of Lichen Planus as part of broader dermatology and autoimmune disease management policies. The Australian government has established public health frameworks for skin conditions and autoimmune disorders, which help improve the access and affordability of treatments. However, there are no specific policies dedicated solely to Lichen Planus. The government supports research through funding agencies like the NHMRC, which can contribute to developing new treatments for autoimmune diseases. The TGA regulates topical and oral medications used to manage Lichen Planus, ensuring their safety and efficacy in clinical practice.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Lichen Planus Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Lichen Planus Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Lichen Planus Market - Industry Life Cycle |
3.4 Australia Lichen Planus Market - Porter's Five Forces |
3.5 Australia Lichen Planus Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Australia Lichen Planus Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Australia Lichen Planus Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Australia Lichen Planus Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Lichen Planus Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Lichen Planus Market Trends |
6 Australia Lichen Planus Market, By Types |
6.1 Australia Lichen Planus Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Lichen Planus Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Australia Lichen Planus Market Revenues & Volume, By Retinoids, 2021- 2031F |
6.1.4 Australia Lichen Planus Market Revenues & Volume, By CorticosteroidsAntihistamines, 2021- 2031F |
6.1.5 Australia Lichen Planus Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Lichen Planus Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Lichen Planus Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Australia Lichen Planus Market Revenues & Volume, By Topical, 2021- 2031F |
6.2.4 Australia Lichen Planus Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Lichen Planus Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Australia Lichen Planus Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Lichen Planus Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Australia Lichen Planus Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Australia Lichen Planus Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Lichen Planus Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Lichen Planus Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Australia Lichen Planus Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Australia Lichen Planus Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Lichen Planus Market Import-Export Trade Statistics |
7.1 Australia Lichen Planus Market Export to Major Countries |
7.2 Australia Lichen Planus Market Imports from Major Countries |
8 Australia Lichen Planus Market Key Performance Indicators |
9 Australia Lichen Planus Market - Opportunity Assessment |
9.1 Australia Lichen Planus Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Australia Lichen Planus Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Australia Lichen Planus Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Australia Lichen Planus Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Lichen Planus Market - Competitive Landscape |
10.1 Australia Lichen Planus Market Revenue Share, By Companies, 2024 |
10.2 Australia Lichen Planus Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |